Jeff Fairman, VP, Research at Vaxcyte, Inc. (PCVX), sold 9,500 shares at $22.50 ($214K) on 2021-06-07, disclosed to the SEC on 2021-06-09.
Open-market sale of $214k PCVX by VP, Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PCVX | SELL | 2022-09-07 | $257K | — | Filing → |
| PCVX | SELL | 2022-08-05 | $384K | — | Filing → |
| PCVX | SELL | 2022-05-24 | $105K | — | Filing → |